ECONOMIC BURDEN OF DISABILITY ADJUSTED LIFE YEARS (DALYs) OF CANCER IN TURKEY

Öz

Aim: Cancer is one of the leading causes of premature death in the world. However, the economic burden of cancer at the country level is unknown. This study aims to estimate the economic loss of disability- adjusted life years (DALYs) lost due to cancer between 1990 and 2019 in Turkey. Methods: The economic value of DALYs lost to cancer has been estimated using the human capital approach. This study used disability-adjusted life years and gross domestic product (GDP) per capita to estimate economic loss due to DALYs in Turkey. Corresponding author: Arzu YİĞİT, Assoc. Dr. Süleyman Demirel University, Faculty of Economics and Administrative Sciences, Department of Health Management, Isparta, Turkey e mail: [e-mail] Results: Total economic loss due to cancer due to DALYs in 1990 was estimated as $ 3,366,235,623 (CI: $3,366,235,623- $ 5,822,580,496). In 2019, the total economic loss due to DALYs-related cancer was estimated to be $21,219,951,335 (95% CI: $16,172,564,722- $26,781,505,239). While the economic value of DALYs lost due to cancer was 3.0 (CI: 2.23-3.86) % of GDP in 1990 in Turkey, it was 2.79 (95% CI: 2.13-3.52) % of GDP in 2019. Conclusion: According to the findings obtained from the research findings, an economic value of roughly 2.8 % of the GDP in Turkey shows that due to cancers. The first cancer, which constitutes the highest economic value of DALYs are lung cancer (28%) with 5.9 billion $. This finding necessitates the meticulous implementation of Turkey’s national cancer policy for cancer prevention in Turkey.

Anahtar Kelimeler

• Cancer
• indirect costs
• DALYs
• human capital

Kaynakça

1. Bhanvadia, S. K., Psutka, S. P., Burg, M. L., de Wit, R., Dhillon, H. M., Gyawali, B., ... Penson, D. F. (2021). Financial Toxicity Among Patients with Prostate, Bladder, and Kidney Cancer: A Systematic Review and Call to Action. European Urology Oncology, 4(3), 396–404. https://doi.org/10.1016/J.EUO.2021.02.007
2. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/CAAC.21492
3. Brown, D. W. (2008). Economic value of disability-adjusted life years lost to violence: Estimates for WHO Member States. Revista Panamericana de Salud Publica/Pan American Journal of Public Health, 24(3). https://doi.org/10.1590/S1020-49892008000900007
4. Dalal, K., & Svanström, L. (2015). Economic Burden of Disability Adjusted Life Years (DALYs) of Injuries. Health, 07(04), 487–494. https://doi.org/10.4236/health.2015.74058
5. Demirer, T. (2014). TÜBA National Cancer Policies Workshop Report. Turkey, Ankara.
6. Garlasco, J., Nurchis, M. C., Bordino, V., Sapienza, M., Altamura, G., Damiani, G., & Gianino, M. M. (2022). Cancers: What Are the Costs in Relation to Disability-Adjusted Life Years? A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health, 19(8), 4862. https://doi.org/10.3390/ijerph19084862
7. Hanly, P. A., & Sharp, L. (2014). The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden. BMC Cancer, 14(1), 224. https://doi.org/10.1186/1471- 2407-14-224
8. Hanly, P., Soerjomataram, I., & Sharp, L. (2015). Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer-related mortality in Europe. International Journal of Cancer, 136(4), E136–E145. https://doi.org/10.1002/IJC.29105

9. Hay, S. I., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., ... Bryane, C. E. G. (2017). Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1260– 1344. https://doi.org/10.1016/S0140-6736(17)32130-X
10. IHME (2022). Institute for Health Metrics and Evaluation. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 Results. Seattle, United States. Accessed: 15.10.2022 Jimenez de la Jara, J., Bastias, G., Ferreccio, C., Moscoso, C., Sagues, S., Cid, C., ... Owen, G. I. (2015). A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy. Biological Research, 48(1), 10. https://doi.org/10.1186/0717-6287-48-10
11. John, R. M., & Ross, H. (2010). Economic value of disability adjusted life years lost to cancers: 2008. Journal of Clinical Oncology, 28(15_suppl), 1561–1561. https://doi.org/10.1200/jco.2010.28.15_suppl.1561
12. McCormick, P. J. (2018). Cancer Tsunami: Emerging Trends, Economic Burden, and Perioperative Implications. Current Anesthesiology Reports, 8(4), 348–354. https://doi.org/10.1007/s40140-018- 0294-1
13. Murray, C. J. ., & Lopez, A. D. (1996). The global burden of disease. Boston: WHO, Harvard School of Public Health, World Bank.
14. Muthuri, R. N. D. K., & Kirigia, J. M. (2020). The Monetary Value of Disability-Adjusted Life Years in Kenya in 2017. SAGE Open, 10(4), 215824402097055. https://doi.org/10.1177/2158244020970556
15. Naghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., ... Murray, C. J. L. (2017). Global, regional, and national age-sex specific mortality for 264 causes of death, 1980– 2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1151–1210. https://doi.org/10.1016/S0140-6736(17)32152-9
16. OECD (2022). OECD Health Statistics 2022. https://www.oecd.org/els/health-systems/health-data.htm Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/CAAC.21660
17. TUİK (2022). https://www.tuik.gov.tr/. Accessed: 11.10. 2022 Unar-Munguía, M., Meza, R., Colchero, M. A., Torres-Mejía, G., & de Cosío, T. G. (2017). Economic and disease burden of breast cancer associated with suboptimal breastfeeding practices in Mexico.
18. Cancer Causes & Control, 28(12), 1381–1391. https://doi.org/10.1007/s10552-017-0965-0
19. Vos, T., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abate, K. H., Abd-Allah, F., ... Murray, C. J. L. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1211–1259. https://doi.org/10.1016/S0140- 6736(17)32154-2
20. Walker, A. (1997). The economic burden of cancer. International Journal of Care Pathways, 1(2), 72–75. https://doi.org/10.1177/136395959700100207
21. WB (2022). World Bank Database. https://data.worldbank.org/ Accessed: 15 10.2022
22. WHO (2022). Global Health Expenditure Database. https://apps.who.int/nha/database Accessed: 18.09.2022.
23. WHO. (2002). The World Health Organization Report 2002: reducing risks, promoting healthy life. WHO Library Cataloguing-in Publication Data.
24. Yiğit, A., & Yiğit, V. (2019). Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane University Journal of Health Sciences, 8(3), 223–230.
25. Yilmaz, H. H., Yazihan, N., Tunca, D., Sevinç, A., Olcayto, E. Ö., Özgül, N., & Tuncer, M. (2011). Cancer Trends and Incidence and Mortality Patterns in Turkey. Japanese Journal of Clinical Oncology, 41(1), 10–16. https://doi.org/10.1093/JJCO/HYQ075